BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1114881 Cc1sc-2c(c1C)C(=NN(Cc1ccccc1)c1nnc(C)n-21)c1ccc(Cl)cc1 InChI=1S/C23H20ClN5S/c1-14-15(2)30-22-20(14)21(18-9-11-19(24)12-10-18)27-28(13-17-7-5-4-6-8-17)23-26-25-16(3)29(22)23/h4-12H,13H2,1-3H3 BCTGZCYVCUTHMZ-UHFFFAOYSA-N 527549 US11186588, Example 3 Nuclear factor NF-kappa-B p105 subunit Human 51.9 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527549 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527549&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717531 463791123 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114882 Cc1nnc2N(Cc3ccccn3)N=C(c3c(C)c(C)sc3-n12)c1ccc(Cl)cc1 InChI=1S/C22H19ClN6S/c1-13-14(2)30-21-19(13)20(16-7-9-17(23)10-8-16)27-28(12-18-6-4-5-11-24-18)22-26-25-15(3)29(21)22/h4-11H,12H2,1-3H3 RGLRUYOVBCYIDG-UHFFFAOYSA-N 527550 US11186588, Example 5 Nuclear factor NF-kappa-B p105 subunit Human 27.5 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527550 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527550&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717486 463791124 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114883 COc1cccc(CN2N=C(c3c(C)c(C)sc3-n3c(C)nnc23)c2ccc(Cl)cc2)c1 InChI=1S/C24H22ClN5OS/c1-14-15(2)32-23-21(14)22(18-8-10-19(25)11-9-18)28-29(24-27-26-16(3)30(23)24)13-17-6-5-7-20(12-17)31-4/h5-12H,13H2,1-4H3 UHGZEBBHFRSDNY-UHFFFAOYSA-N 527551 US11186588, Example 6 Nuclear factor NF-kappa-B p105 subunit Human 86.4 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527551 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527551&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717560 463791125 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114884 Cc1sc-2c(c1C)C(=NN(Cc1ccc(cc1)C(C)(C)C)c1nnc(C)n-21)c1ccc(Cl)cc1 InChI=1S/C27H28ClN5S/c1-16-17(2)34-25-23(16)24(20-9-13-22(28)14-10-20)31-32(26-30-29-18(3)33(25)26)15-19-7-11-21(12-8-19)27(4,5)6/h7-14H,15H2,1-6H3 IGWLTMKQZGMXNC-UHFFFAOYSA-N 527552 US11186588, Example 7 Nuclear factor NF-kappa-B p105 subunit Human 735 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527552 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527552&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717658 463791126 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114885 Cc1nnc2N(Cc3ccccc3F)N=C(c3c(C)c(C)sc3-n12)c1ccc(Cl)cc1 InChI=1S/C23H19ClFN5S/c1-13-14(2)31-22-20(13)21(16-8-10-18(24)11-9-16)28-29(23-27-26-15(3)30(22)23)12-17-6-4-5-7-19(17)25/h4-11H,12H2,1-3H3 RMUUWNUEUOQCPT-UHFFFAOYSA-N 527553 US11186588, Example 8 Nuclear factor NF-kappa-B p105 subunit Human 104 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527553 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527553&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717546 463791127 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114886 Cc1nnc2N(Cc3cccc(F)c3)N=C(c3c(C)c(C)sc3-n12)c1ccc(Cl)cc1 InChI=1S/C23H19ClFN5S/c1-13-14(2)31-22-20(13)21(17-7-9-18(24)10-8-17)28-29(23-27-26-15(3)30(22)23)12-16-5-4-6-19(25)11-16/h4-11H,12H2,1-3H3 KCNKZAXHYSMFSH-UHFFFAOYSA-N 527554 US11186588, Example 9 Nuclear factor NF-kappa-B p105 subunit Human 17.6 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527554 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527554&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717647 463791128 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114887 Cc1sc-2c(c1C)C(=NN(Cc1ccccc1Cl)c1nnc(C)n-21)c1ccc(Cl)cc1 InChI=1S/C23H19Cl2N5S/c1-13-14(2)31-22-20(13)21(16-8-10-18(24)11-9-16)28-29(23-27-26-15(3)30(22)23)12-17-6-4-5-7-19(17)25/h4-11H,12H2,1-3H3 XMOJJOPHVVQICC-UHFFFAOYSA-N 527555 US11186588, Example 10 Nuclear factor NF-kappa-B p105 subunit Human 192 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527555 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527555&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717583 463791129 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114888 Cc1sc-2c(c1C)C(=NN(Cc1ccccc1C)c1nnc(C)n-21)c1ccc(Cl)cc1 InChI=1S/C24H22ClN5S/c1-14-7-5-6-8-19(14)13-29-24-27-26-17(4)30(24)23-21(15(2)16(3)31-23)22(28-29)18-9-11-20(25)12-10-18/h5-12H,13H2,1-4H3 NHUODHLTLYKBDP-UHFFFAOYSA-N 527556 US11186588, Example 11 Nuclear factor NF-kappa-B p105 subunit Human 291 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527556 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527556&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717671 463791130 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114889 Cc1sc-2c(c1C)C(=NN(Cc1cccc(C)c1)c1nnc(C)n-21)c1ccc(Cl)cc1 InChI=1S/C24H22ClN5S/c1-14-6-5-7-18(12-14)13-29-24-27-26-17(4)30(24)23-21(15(2)16(3)31-23)22(28-29)19-8-10-20(25)11-9-19/h5-12H,13H2,1-4H3 DTOPUWHXJUQZEK-UHFFFAOYSA-N 527557 US11186588, Example 12 Nuclear factor NF-kappa-B p105 subunit Human 32.1 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527557 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527557&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717571 463791131 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114890 Cc1sc-2c(c1C)C(=NN(Cc1ccc(C)cc1)c1nnc(C)n-21)c1ccc(Cl)cc1 InChI=1S/C24H22ClN5S/c1-14-5-7-18(8-6-14)13-29-24-27-26-17(4)30(24)23-21(15(2)16(3)31-23)22(28-29)19-9-11-20(25)12-10-19/h5-12H,13H2,1-4H3 WPNUPIPCDWMEEF-UHFFFAOYSA-N 527558 US11186588, Example 13 Nuclear factor NF-kappa-B p105 subunit Human 233 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527558 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527558&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717646 463791132 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114891 Cc1nnc2N(Cc3ccc(cc3)C(F)(F)F)N=C(c3c(C)c(C)sc3-n12)c1ccc(Cl)cc1 InChI=1S/C24H19ClF3N5S/c1-13-14(2)34-22-20(13)21(17-6-10-19(25)11-7-17)31-32(23-30-29-15(3)33(22)23)12-16-4-8-18(9-5-16)24(26,27)28/h4-11H,12H2,1-3H3 URFUKGZFTUDNON-UHFFFAOYSA-N 527559 US11186588, Example 14 Nuclear factor NF-kappa-B p105 subunit Human 276 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527559 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527559&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717547 463791133 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114892 Cc1sc-2c(c1C)C(=NN(Cc1cccc(Cl)c1)c1nnc(C)n-21)c1ccc(Cl)cc1 InChI=1S/C23H19Cl2N5S/c1-13-14(2)31-22-20(13)21(17-7-9-18(24)10-8-17)28-29(23-27-26-15(3)30(22)23)12-16-5-4-6-19(25)11-16/h4-11H,12H2,1-3H3 HUAYBLRYLURKLD-UHFFFAOYSA-N 527560 US11186588, Example 16 Nuclear factor NF-kappa-B p105 subunit Human 77.5 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527560 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527560&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717593 463791134 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114893 Cc1nnc2N(Cc3cccc(c3)C(F)(F)F)N=C(c3c(C)c(C)sc3-n12)c1ccc(Cl)cc1 InChI=1S/C24H19ClF3N5S/c1-13-14(2)34-22-20(13)21(17-7-9-19(25)10-8-17)31-32(23-30-29-15(3)33(22)23)12-16-5-4-6-18(11-16)24(26,27)28/h4-11H,12H2,1-3H3 BSINWWQNCFXUQE-UHFFFAOYSA-N 527561 US11186588, Example 18 Nuclear factor NF-kappa-B p105 subunit Human 144 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527561 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527561&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717513 463791135 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114894 Cc1sc-2c(c1C)C(=NN(CCc1ccccc1)c1nnc(C)n-21)c1ccc(Cl)cc1 InChI=1S/C24H22ClN5S/c1-15-16(2)31-23-21(15)22(19-9-11-20(25)12-10-19)28-29(24-27-26-17(3)30(23)24)14-13-18-7-5-4-6-8-18/h4-12H,13-14H2,1-3H3 XQLQJNBLQWKNBI-UHFFFAOYSA-N 527562 US11186588, Example 19 Nuclear factor NF-kappa-B p105 subunit Human 1322 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527562 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527562&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717599 463791136 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114895 Cc1nnc2N(Cc3cccc(F)n3)N=C(c3c(C)c(C)sc3-n12)c1ccc(Cl)cc1 InChI=1S/C22H18ClFN6S/c1-12-13(2)31-21-19(12)20(15-7-9-16(23)10-8-15)28-29(22-27-26-14(3)30(21)22)11-17-5-4-6-18(24)25-17/h4-10H,11H2,1-3H3 VSAZSZCCLNHXCI-UHFFFAOYSA-N 527563 US11186588, Example 21::US11186588, Example 22 Nuclear factor NF-kappa-B p105 subunit Human 30.3 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527563 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527563&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717670 463791137 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114896 Cc1nnc2N(Cc3cccc(F)n3)N=C(c3c(C)c(C)sc3-n12)c1ccc(Cl)cc1 InChI=1S/C22H18ClFN6S/c1-12-13(2)31-21-19(12)20(15-7-9-16(23)10-8-15)28-29(22-27-26-14(3)30(21)22)11-17-5-4-6-18(24)25-17/h4-10H,11H2,1-3H3 VSAZSZCCLNHXCI-UHFFFAOYSA-N 527563 US11186588, Example 21::US11186588, Example 22 Nuclear factor NF-kappa-B p105 subunit Human 33.6 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527563 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527563&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717670 463791137 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114897 Cc1nnc2N(Cc3ncccc3F)N=C(c3c(C)c(C)sc3-n12)c1ccc(Cl)cc1 InChI=1S/C22H18ClFN6S/c1-12-13(2)31-21-19(12)20(15-6-8-16(23)9-7-15)28-29(22-27-26-14(3)30(21)22)11-18-17(24)5-4-10-25-18/h4-10H,11H2,1-3H3 LDORQALIFYFEJW-UHFFFAOYSA-N 527565 US11186588, Example 23 Nuclear factor NF-kappa-B p105 subunit Human 158 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527565 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527565&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717577 463791138 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114898 Cc1nnc2N(Cc3ncccc3Cl)N=C(c3c(C)c(C)sc3-n12)c1ccc(Cl)cc1 InChI=1S/C22H18Cl2N6S/c1-12-13(2)31-21-19(12)20(15-6-8-16(23)9-7-15)28-29(22-27-26-14(3)30(21)22)11-18-17(24)5-4-10-25-18/h4-10H,11H2,1-3H3 UEJCLWBTEVOXGF-UHFFFAOYSA-N 527566 US11186588, Example 24 Nuclear factor NF-kappa-B p105 subunit Human 1055 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527566 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527566&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717498 463791139 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114899 Cc1nnc2N(Cc3cccnc3F)N=C(c3c(C)c(C)sc3-n12)c1ccc(Cl)cc1 InChI=1S/C22H18ClFN6S/c1-12-13(2)31-21-18(12)19(15-6-8-17(23)9-7-15)28-29(22-27-26-14(3)30(21)22)11-16-5-4-10-25-20(16)24/h4-10H,11H2,1-3H3 WAJYRPYTVWSRKD-UHFFFAOYSA-N 527567 US11186588, Example 25 Nuclear factor NF-kappa-B p105 subunit Human 50.3 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527567 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527567&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717499 463791140 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114900 Cc1nnc2N(Cc3ccc(F)nc3)N=C(c3c(C)c(C)sc3-n12)c1ccc(Cl)cc1 InChI=1S/C22H18ClFN6S/c1-12-13(2)31-21-19(12)20(16-5-7-17(23)8-6-16)28-29(22-27-26-14(3)30(21)22)11-15-4-9-18(24)25-10-15/h4-10H,11H2,1-3H3 PPBZDSWVLHZYGR-UHFFFAOYSA-N 527568 US11186588, Example 26 Nuclear factor NF-kappa-B p105 subunit Human 12.3 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527568 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527568&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717556 463791141 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114901 Cc1sc-2c(c1C)C(=NNc1nnc(C)n-21)c1ccccc1 InChI=1S/C16H15N5S/c1-9-10(2)22-15-13(9)14(12-7-5-4-6-8-12)18-20-16-19-17-11(3)21(15)16/h4-8H,1-3H3,(H,19,20) QEJVJWMPFVGSDL-UHFFFAOYSA-N 527569 US11186588, Example 27 Nuclear factor NF-kappa-B p105 subunit Human 3102 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527569 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527569&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 135703264 463791142 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114902 Cc1sc-2c(c1C)C(=NN(Cc1ccccc1)c1nnc(C)n-21)c1ccccc1 InChI=1S/C23H21N5S/c1-15-16(2)29-22-20(15)21(19-12-8-5-9-13-19)26-27(14-18-10-6-4-7-11-18)23-25-24-17(3)28(22)23/h4-13H,14H2,1-3H3 QHYYWZZOOJHCON-UHFFFAOYSA-N 527570 US11186588, Example 29 Nuclear factor NF-kappa-B p105 subunit Human 265 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527570 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527570&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717502 463791143 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114903 Cc1nnc2N(Cc3ccccn3)N=C(c3c(C)c(C)sc3-n12)c1ccccc1 InChI=1S/C22H20N6S/c1-14-15(2)29-21-19(14)20(17-9-5-4-6-10-17)26-27(13-18-11-7-8-12-23-18)22-25-24-16(3)28(21)22/h4-12H,13H2,1-3H3 SWXKESFJPFLVOX-UHFFFAOYSA-N 527571 US11186588, Example 31 Nuclear factor NF-kappa-B p105 subunit Human 150 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527571 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527571&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717664 463791144 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114904 COc1cccc(CN2N=C(c3c(C)c(C)sc3-n3c(C)nnc23)c2ccccc2)c1 InChI=1S/C24H23N5OS/c1-15-16(2)31-23-21(15)22(19-10-6-5-7-11-19)27-28(24-26-25-17(3)29(23)24)14-18-9-8-12-20(13-18)30-4/h5-13H,14H2,1-4H3 VUYZPONSLPSWIN-UHFFFAOYSA-N 527572 US11186588, Example 33 Nuclear factor NF-kappa-B p105 subunit Human 87.2 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527572 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527572&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717638 463791145 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114905 COc1ccccc1CN1N=C(c2c(C)c(C)sc2-n2c(C)nnc12)c1ccc(Cl)cc1 InChI=1S/C24H22ClN5OS/c1-14-15(2)32-23-21(14)22(17-9-11-19(25)12-10-17)28-29(24-27-26-16(3)30(23)24)13-18-7-5-6-8-20(18)31-4/h5-12H,13H2,1-4H3 JYAZZXHVUPIWOW-UHFFFAOYSA-N 527573 US11186588, Example 34 Nuclear factor NF-kappa-B p105 subunit Human 612 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527573 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527573&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717515 463791146 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114906 Cc1nnc2N(Cc3ccc(Cl)cn3)N=C(c3c(C)c(C)sc3-n12)c1ccc(Cl)cc1 InChI=1S/C22H18Cl2N6S/c1-12-13(2)31-21-19(12)20(15-4-6-16(23)7-5-15)28-29(22-27-26-14(3)30(21)22)11-18-9-8-17(24)10-25-18/h4-10H,11H2,1-3H3 UBXFMZQPXGGCRK-UHFFFAOYSA-N 527574 US11186588, Example 36 Nuclear factor NF-kappa-B p105 subunit Human 401 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527574 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527574&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717587 463791147 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114907 Cc1nnc2N(Cc3cccnc3Cl)N=C(c3c(C)c(C)sc3-n12)c1ccc(Cl)cc1 InChI=1S/C22H18Cl2N6S/c1-12-13(2)31-21-18(12)19(15-6-8-17(23)9-7-15)28-29(22-27-26-14(3)30(21)22)11-16-5-4-10-25-20(16)24/h4-10H,11H2,1-3H3 GGBBIFBRHFQMEO-UHFFFAOYSA-N 527575 US11186588, Example 38 Nuclear factor NF-kappa-B p105 subunit Human 106 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527575 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527575&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717635 463791148 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114908 Cc1nnc2N(Cc3cncc(Cl)c3)N=C(c3c(C)c(C)sc3-n12)c1ccc(Cl)cc1 InChI=1S/C22H18Cl2N6S/c1-12-13(2)31-21-19(12)20(16-4-6-17(23)7-5-16)28-29(22-27-26-14(3)30(21)22)11-15-8-18(24)10-25-9-15/h4-10H,11H2,1-3H3 WMRQTYBESZSSAM-UHFFFAOYSA-N 527576 US11186588, Example 39 Nuclear factor NF-kappa-B p105 subunit Human 620 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527576 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527576&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717624 463791149 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114909 Cc1nnc2N(Cc3cc(Cl)ccn3)N=C(c3c(C)c(C)sc3-n12)c1ccc(Cl)cc1 InChI=1S/C22H18Cl2N6S/c1-12-13(2)31-21-19(12)20(15-4-6-16(23)7-5-15)28-29(22-27-26-14(3)30(21)22)11-18-10-17(24)8-9-25-18/h4-10H,11H2,1-3H3 XXCPFIKRLIEPOD-UHFFFAOYSA-N 527577 US11186588, Example 40 Nuclear factor NF-kappa-B p105 subunit Human 699 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527577 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527577&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717675 463791150 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114910 Cc1nnc2N(Cc3ccnc(F)c3)N=C(c3c(C)c(C)sc3-n12)c1ccc(Cl)cc1 InChI=1S/C22H18ClFN6S/c1-12-13(2)31-21-19(12)20(16-4-6-17(23)7-5-16)28-29(22-27-26-14(3)30(21)22)11-15-8-9-25-18(24)10-15/h4-10H,11H2,1-3H3 JGYNADNNEHYRLZ-UHFFFAOYSA-N 527578 US11186588, Example 42 Nuclear factor NF-kappa-B p105 subunit Human 1148 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527578 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527578&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717645 463791151 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114911 Cc1nnc2N(Cc3cnccc3Cl)N=C(c3c(C)c(C)sc3-n12)c1ccc(Cl)cc1 InChI=1S/C22H18Cl2N6S/c1-12-13(2)31-21-19(12)20(15-4-6-17(23)7-5-15)28-29(22-27-26-14(3)30(21)22)11-16-10-25-9-8-18(16)24/h4-10H,11H2,1-3H3 YRPLFXVJKPIDNQ-UHFFFAOYSA-N 527579 US11186588, Example 43 Nuclear factor NF-kappa-B p105 subunit Human 1833 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527579 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527579&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717534 463791152 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114912 Cc1nnc2N(CCc3c[nH]c4ccccc34)N=C(c3c(C)c(C)sc3-n12)c1ccc(Cl)cc1 InChI=1S/C26H23ClN6S/c1-15-16(2)34-25-23(15)24(18-8-10-20(27)11-9-18)31-32(26-30-29-17(3)33(25)26)13-12-19-14-28-22-7-5-4-6-21(19)22/h4-11,14,28H,12-13H2,1-3H3 JGNNBOACYUMDOV-UHFFFAOYSA-N 527580 US11186588, Example 44 Nuclear factor NF-kappa-B p105 subunit Human 9850 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527580 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527580&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717490 463791153 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114913 Cc1nnc2N(Cc3cccs3)N=C(c3c(C)c(C)sc3-n12)c1ccc(Cl)cc1 InChI=1S/C21H18ClN5S2/c1-12-13(2)29-20-18(12)19(15-6-8-16(22)9-7-15)25-26(11-17-5-4-10-28-17)21-24-23-14(3)27(20)21/h4-10H,11H2,1-3H3 QNXZRUHRRWKPIR-UHFFFAOYSA-N 527581 US11186588, Example 45 Nuclear factor NF-kappa-B p105 subunit Human 429 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527581 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527581&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717621 463791154 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114914 COc1cccc(CN2N=C(c3c(C)c(C)sc3-n3c(C)nnc23)c2ccc(Cl)cc2)n1 InChI=1S/C23H21ClN6OS/c1-13-14(2)32-22-20(13)21(16-8-10-17(24)11-9-16)28-29(23-27-26-15(3)30(22)23)12-18-6-5-7-19(25-18)31-4/h5-11H,12H2,1-4H3 AQMOASCHPVSIJV-UHFFFAOYSA-N 527582 US11186588, Example 46 Nuclear factor NF-kappa-B p105 subunit Human 683 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527582 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527582&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717642 463791155 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114915 COc1ccc(CN2N=C(c3c(C)c(C)sc3-n3c(C)nnc23)c2ccc(Cl)cc2)nc1 InChI=1S/C23H21ClN6OS/c1-13-14(2)32-22-20(13)21(16-5-7-17(24)8-6-16)28-29(23-27-26-15(3)30(22)23)12-18-9-10-19(31-4)11-25-18/h5-11H,12H2,1-4H3 IPMMZJLKVSQSRW-UHFFFAOYSA-N 527583 US11186588, Example 47 Nuclear factor NF-kappa-B p105 subunit Human 554 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527583 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527583&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717506 463791156 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114916 COc1ccnc(CN2N=C(c3c(C)c(C)sc3-n3c(C)nnc23)c2ccc(Cl)cc2)c1 InChI=1S/C23H21ClN6OS/c1-13-14(2)32-22-20(13)21(16-5-7-17(24)8-6-16)28-29(23-27-26-15(3)30(22)23)12-18-11-19(31-4)9-10-25-18/h5-11H,12H2,1-4H3 KICOGAWWDXIPSR-UHFFFAOYSA-N 527584 US11186588, Example 48 Nuclear factor NF-kappa-B p105 subunit Human 297 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527584 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527584&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717487 463791157 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114917 COc1ncccc1CN1N=C(c2c(C)c(C)sc2-n2c(C)nnc12)c1ccc(Cl)cc1 InChI=1S/C23H21ClN6OS/c1-13-14(2)32-22-19(13)20(16-7-9-18(24)10-8-16)28-29(23-27-26-15(3)30(22)23)12-17-6-5-11-25-21(17)31-4/h5-11H,12H2,1-4H3 PTVATHBLNYBGMU-UHFFFAOYSA-N 527585 US11186588, Example 49 Nuclear factor NF-kappa-B p105 subunit Human 197 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527585 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527585&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717527 463791158 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114918 COc1ccc(CN2N=C(c3c(C)c(C)sc3-n3c(C)nnc23)c2ccc(Cl)cc2)cn1 InChI=1S/C23H21ClN6OS/c1-13-14(2)32-22-20(13)21(17-6-8-18(24)9-7-17)28-29(23-27-26-15(3)30(22)23)12-16-5-10-19(31-4)25-11-16/h5-11H,12H2,1-4H3 NKMXIBHXKGFXTN-UHFFFAOYSA-N 527586 US11186588, Example 50 Nuclear factor NF-kappa-B p105 subunit Human 355 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527586 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527586&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717478 463791159 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114919 COc1ccncc1CN1N=C(c2c(C)c(C)sc2-n2c(C)nnc12)c1ccc(Cl)cc1 InChI=1S/C23H21ClN6OS/c1-13-14(2)32-22-20(13)21(16-5-7-18(24)8-6-16)28-29(23-27-26-15(3)30(22)23)12-17-11-25-10-9-19(17)31-4/h5-11H,12H2,1-4H3 LNFRRTBZQHQJNZ-UHFFFAOYSA-N 527587 US11186588, Example 51 Nuclear factor NF-kappa-B p105 subunit Human 265 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527587 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527587&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717648 463791160 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114920 Cc1nnc2N(Cc3cccc(N)c3)N=C(c3c(C)c(C)sc3-n12)c1ccc(Cl)cc1 InChI=1S/C23H21ClN6S/c1-13-14(2)31-22-20(13)21(17-7-9-18(24)10-8-17)28-29(23-27-26-15(3)30(22)23)12-16-5-4-6-19(25)11-16/h4-11H,12,25H2,1-3H3 GPYVUSHYLRDFGK-UHFFFAOYSA-N 527588 US11186588, Example 52 Nuclear factor NF-kappa-B p105 subunit Human 5233 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527588 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527588&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717581 463791161 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114921 Cc1nnc2N(Cc3cccc(O)c3)N=C(c3c(C)c(C)sc3-n12)c1ccc(Cl)cc1 InChI=1S/C23H20ClN5OS/c1-13-14(2)31-22-20(13)21(17-7-9-18(24)10-8-17)27-28(23-26-25-15(3)29(22)23)12-16-5-4-6-19(30)11-16/h4-11,30H,12H2,1-3H3 ZHMSBPDDQKNEKK-UHFFFAOYSA-N 527589 US11186588, Example 53 Nuclear factor NF-kappa-B p105 subunit Human 2982 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527589 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527589&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717600 463791162 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114922 CN(C)c1cccc(CN2N=C(c3c(C)c(C)sc3-n3c(C)nnc23)c2ccc(Cl)cc2)c1 InChI=1S/C25H25ClN6S/c1-15-16(2)33-24-22(15)23(19-9-11-20(26)12-10-19)29-31(25-28-27-17(3)32(24)25)14-18-7-6-8-21(13-18)30(4)5/h6-13H,14H2,1-5H3 WEXNHNKLFULWJL-UHFFFAOYSA-N 527590 US11186588, Example 55 Nuclear factor NF-kappa-B p105 subunit Human 2763 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527590 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527590&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717555 463791163 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114923 CC(=O)Nc1cc(CN2N=C(c3c(C)c(C)sc3-n3c(C)nnc23)c2ccc(Cl)cc2)ccn1 InChI=1S/C24H22ClN7OS/c1-13-14(2)34-23-21(13)22(18-5-7-19(25)8-6-18)30-31(24-29-28-15(3)32(23)24)12-17-9-10-26-20(11-17)27-16(4)33/h5-11H,12H2,1-4H3,(H,26,27,33) GWFPOTBSVGKTBB-UHFFFAOYSA-N 527591 US11186588, Example 56 Nuclear factor NF-kappa-B p105 subunit Human 942 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527591 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527591&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717594 463791164 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114924 Cc1nnc2N(Cc3ccnc(N)c3)N=C(c3c(C)c(C)sc3-n12)c1ccc(Cl)cc1 InChI=1S/C22H20ClN7S/c1-12-13(2)31-21-19(12)20(16-4-6-17(23)7-5-16)28-29(22-27-26-14(3)30(21)22)11-15-8-9-25-18(24)10-15/h4-10H,11H2,1-3H3,(H2,24,25) SVNBMLAWEQWYEC-UHFFFAOYSA-N 527592 US11186588, Example 57 Nuclear factor NF-kappa-B p105 subunit Human 558 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527592 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527592&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717477 463791165 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114925 COc1ccc(CN2N=C(c3ccsc3-n3c(C)nnc23)c2ccc(Cl)cc2)cc1 InChI=1S/C22H18ClN5OS/c1-14-24-25-22-27(13-15-3-9-18(29-2)10-4-15)26-20(16-5-7-17(23)8-6-16)19-11-12-30-21(19)28(14)22/h3-12H,13H2,1-2H3 RFQQGYJWAVDUFF-UHFFFAOYSA-N 527593 64::US11186588, Example 58 Nuclear factor NF-kappa-B p105 subunit Homo sapiens 728 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 Ayumi Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527593 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527593&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 2O61,8TQD,9BOR,1NFI,7RG5,7RG4 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114926 Cc1nnc2N(Cc3ccccc3)N=C(c3ccsc3-n12)c1ccc(Cl)cc1 InChI=1S/C21H16ClN5S/c1-14-23-24-21-26(13-15-5-3-2-4-6-15)25-19(16-7-9-17(22)10-8-16)18-11-12-28-20(18)27(14)21/h2-12H,13H2,1H3 UJXCBYNFHVRPPD-UHFFFAOYSA-N 527594 US11186588, Example 60 Nuclear factor NF-kappa-B p105 subunit Human 1686 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527594 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527594&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717617 463791167 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114927 Cc1nnc2N(Cc3cccnc3)N=C(c3ccsc3-n12)c1ccc(Cl)cc1 InChI=1S/C20H15ClN6S/c1-13-23-24-20-26(12-14-3-2-9-22-11-14)25-18(15-4-6-16(21)7-5-15)17-8-10-28-19(17)27(13)20/h2-11H,12H2,1H3 FPUGAQZBRFXXKQ-UHFFFAOYSA-N 527595 US11186588, Example 61 Nuclear factor NF-kappa-B p105 subunit Human 377 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527595 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527595&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717548 463791168 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114928 Cc1nnc2N(Cc3ccncc3)N=C(c3ccsc3-n12)c1ccc(Cl)cc1 InChI=1S/C20H15ClN6S/c1-13-23-24-20-26(12-14-6-9-22-10-7-14)25-18(15-2-4-16(21)5-3-15)17-8-11-28-19(17)27(13)20/h2-11H,12H2,1H3 AHGAZADCKVMGOA-UHFFFAOYSA-N 527596 US11186588, Example 63 Nuclear factor NF-kappa-B p105 subunit Human 5236 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527596 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527596&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717519 463791169 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114929 COc1cccc(CN2N=C(c3ccsc3-n3c(C)nnc23)c2ccc(Cl)cc2)c1 InChI=1S/C22H18ClN5OS/c1-14-24-25-22-27(13-15-4-3-5-18(12-15)29-2)26-20(16-6-8-17(23)9-7-16)19-10-11-30-21(19)28(14)22/h3-12H,13H2,1-2H3 NVNLJJXSMOMBAP-UHFFFAOYSA-N 527597 US11186588, Example 64 Nuclear factor NF-kappa-B p105 subunit Human 5492 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527597 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527597&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717660 463791170 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114930 COc1ccc(CN(N)C(=S)Nc2sc(C)cc2C(=O)c2ccc(Cl)cc2)cc1 InChI=1S/C21H20ClN3O2S2/c1-13-11-18(19(26)15-5-7-16(22)8-6-15)20(29-13)24-21(28)25(23)12-14-3-9-17(27-2)10-4-14/h3-11H,12,23H2,1-2H3,(H,24,28) MOGHLKXFOUCDAN-UHFFFAOYSA-N 527598 US11186588, Example 65 Nuclear factor NF-kappa-B p105 subunit Human 896 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527598 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527598&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717584 463791171 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114931 Cc1sc(NC(=S)N(N)Cc2cccnc2)c(C(=O)c2ccc(cc2)[N+]([O-])=O)c1C InChI=1S/C20H19N5O3S2/c1-12-13(2)30-19(23-20(29)24(21)11-14-4-3-9-22-10-14)17(12)18(26)15-5-7-16(8-6-15)25(27)28/h3-10H,11,21H2,1-2H3,(H,23,29) VSOQWTZONLEHIW-UHFFFAOYSA-N 527599 US11186588, Example 70 Nuclear factor NF-kappa-B p105 subunit Human 1834 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527599 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527599&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717590 463791172 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114932 CC(=O)Nc1ccc(cc1)C(=O)c1c(C)c(C)sc1NC(=S)N(N)Cc1cccnc1 InChI=1S/C22H23N5O2S2/c1-13-14(2)31-21(26-22(30)27(23)12-16-5-4-10-24-11-16)19(13)20(29)17-6-8-18(9-7-17)25-15(3)28/h4-11H,12,23H2,1-3H3,(H,25,28)(H,26,30) OLTPBPWPDGIIPG-UHFFFAOYSA-N 527600 US11186588, Example 71 Nuclear factor NF-kappa-B p105 subunit Human 634 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527600 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527600&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717576 463791173 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114933 Cc1sc(NC(=S)N(N)Cc2cccnc2)c(C(=O)c2cccc(Cl)c2)c1C InChI=1S/C20H19ClN4OS2/c1-12-13(2)28-19(17(12)18(26)15-6-3-7-16(21)9-15)24-20(27)25(22)11-14-5-4-8-23-10-14/h3-10H,11,22H2,1-2H3,(H,24,27) FMUBHTYAUNLXLC-UHFFFAOYSA-N 527601 US11186588, Example 73 Nuclear factor NF-kappa-B p105 subunit Human 246 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527601 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527601&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717538 463791174 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114934 COc1ccccc1C(=O)c1c(C)c(C)sc1NC(=S)N(N)Cc1cccnc1 InChI=1S/C21H22N4O2S2/c1-13-14(2)29-20(18(13)19(26)16-8-4-5-9-17(16)27-3)24-21(28)25(22)12-15-7-6-10-23-11-15/h4-11H,12,22H2,1-3H3,(H,24,28) JEXWGTPFODNSFI-UHFFFAOYSA-N 527602 US11186588, Example 74 Nuclear factor NF-kappa-B p105 subunit Human 2139 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527602 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527602&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717631 463791175 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114935 COc1cccc(c1)C1=NN(Cc2cccnc2)c2nnc(C)n2-c2sc(C)c(C)c12 InChI=1S/C23H22N6OS/c1-14-15(2)31-22-20(14)21(18-8-5-9-19(11-18)30-4)27-28(13-17-7-6-10-24-12-17)23-26-25-16(3)29(22)23/h5-12H,13H2,1-4H3 JBMYPQQAQCZYOG-UHFFFAOYSA-N 527603 US11186588, Example 75 Nuclear factor NF-kappa-B p105 subunit Human 1927 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527603 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527603&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717630 463791176 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114936 Cc1nnc2N(Cc3cccnc3C#N)N=C(c3c(C)c(C)sc3-n12)c1ccc(Cl)cc1 InChI=1S/C23H18ClN7S/c1-13-14(2)32-22-20(13)21(16-6-8-18(24)9-7-16)29-30(23-28-27-15(3)31(22)23)12-17-5-4-10-26-19(17)11-25/h4-10H,12H2,1-3H3 ZVRATAMGBBVMLX-UHFFFAOYSA-N 527604 US11186588, Example 77 Nuclear factor NF-kappa-B p105 subunit Human 1952 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527604 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527604&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717525 463791177 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114937 Cc1nnc2N(Cc3cccnc3C(F)(F)F)N=C(c3c(C)c(C)sc3-n12)c1ccc(Cl)cc1 InChI=1S/C23H18ClF3N6S/c1-12-13(2)34-21-18(12)19(15-6-8-17(24)9-7-15)31-32(22-30-29-14(3)33(21)22)11-16-5-4-10-28-20(16)23(25,26)27/h4-10H,11H2,1-3H3 VSJMGVGJMLYJIO-UHFFFAOYSA-N 527605 US11186588, Example 78 Nuclear factor NF-kappa-B p105 subunit Human 1260 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527605 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527605&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717532 463791178 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114938 Cc1nnc2N(Cc3cccnc3Br)N=C(c3c(C)c(C)sc3-n12)c1ccc(Cl)cc1 InChI=1S/C22H18BrClN6S/c1-12-13(2)31-21-18(12)19(15-6-8-17(24)9-7-15)28-29(22-27-26-14(3)30(21)22)11-16-5-4-10-25-20(16)23/h4-10H,11H2,1-3H3 HMVBANQJZUMMRC-UHFFFAOYSA-N 527606 US11186588, Example 79 Nuclear factor NF-kappa-B p105 subunit Human 742 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527606 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527606&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717482 463791179 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114939 Cc1nnc2N(Cc3cccnc3[N+]([O-])=O)N=C(c3c(C)c(C)sc3-n12)c1ccc(Cl)cc1 InChI=1S/C22H18ClN7O2S/c1-12-13(2)33-21-18(12)19(15-6-8-17(23)9-7-15)27-28(22-26-25-14(3)29(21)22)11-16-5-4-10-24-20(16)30(31)32/h4-10H,11H2,1-3H3 PKYUBQKOELAESF-UHFFFAOYSA-N 527607 US11186588, Example 80 Nuclear factor NF-kappa-B p105 subunit Human 1109 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527607 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527607&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717677 463791180 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114940 Cc1nnc2N(Cc3cccnc3N)N=C(c3c(C)c(C)sc3-n12)c1ccc(Cl)cc1 InChI=1S/C22H20ClN7S/c1-12-13(2)31-21-18(12)19(15-6-8-17(23)9-7-15)28-29(22-27-26-14(3)30(21)22)11-16-5-4-10-25-20(16)24/h4-10H,11H2,1-3H3,(H2,24,25) GCTPGYUATLSCJI-UHFFFAOYSA-N 527608 US11186588, Example 81 Nuclear factor NF-kappa-B p105 subunit Human 47.2 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527608 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527608&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717567 463791181 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114941 CC(=O)Nc1ncccc1CN1N=C(c2c(C)c(C)sc2-n2c(C)nnc12)c1ccc(Cl)cc1 InChI=1S/C24H22ClN7OS/c1-13-14(2)34-23-20(13)21(17-7-9-19(25)10-8-17)30-31(24-29-28-15(3)32(23)24)12-18-6-5-11-26-22(18)27-16(4)33/h5-11H,12H2,1-4H3,(H,26,27,33) LCRJJKGHNQVHIQ-UHFFFAOYSA-N 527609 US11186588, Example 82 Nuclear factor NF-kappa-B p105 subunit Human 135 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527609 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527609&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717589 463791182 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114942 COC(=O)c1ncccc1CN1N=C(c2c(C)c(C)sc2-n2c(C)nnc12)c1ccc(Cl)cc1 InChI=1S/C24H21ClN6O2S/c1-13-14(2)34-22-19(13)20(16-7-9-18(25)10-8-16)29-30(24-28-27-15(3)31(22)24)12-17-6-5-11-26-21(17)23(32)33-4/h5-11H,12H2,1-4H3 OPAISOVMFZXKIN-UHFFFAOYSA-N 527610 US11186588, Example 83::US11186588, Example 86 Nuclear factor NF-kappa-B p105 subunit Human 2818 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527610 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527610&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717504 463791183 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114943 COC(=O)c1ncccc1CN1N=C(c2c(C)c(C)sc2-n2c(C)nnc12)c1ccc(Cl)cc1 InChI=1S/C24H21ClN6O2S/c1-13-14(2)34-22-19(13)20(16-7-9-18(25)10-8-16)29-30(24-28-27-15(3)31(22)24)12-17-6-5-11-26-21(17)23(32)33-4/h5-11H,12H2,1-4H3 OPAISOVMFZXKIN-UHFFFAOYSA-N 527610 US11186588, Example 83::US11186588, Example 86 Nuclear factor NF-kappa-B p105 subunit Human 95.3 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527610 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527610&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717504 463791183 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114944 CCOc1ncccc1CN1N=C(c2c(C)c(C)sc2-n2c(C)nnc12)c1ccc(Cl)cc1 InChI=1S/C24H23ClN6OS/c1-5-32-22-18(7-6-12-26-22)13-30-24-28-27-16(4)31(24)23-20(14(2)15(3)33-23)21(29-30)17-8-10-19(25)11-9-17/h6-12H,5,13H2,1-4H3 CWCAROJPQMMLBQ-UHFFFAOYSA-N 527612 US11186588, Example 87 Nuclear factor NF-kappa-B p105 subunit Human 1393 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527612 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527612&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717588 463791184 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114945 Cc1nnc2N(Cc3cc(F)cnc3F)N=C(c3c(C)c(C)sc3-n12)c1ccc(Cl)cc1 InChI=1S/C22H17ClF2N6S/c1-11-12(2)32-21-18(11)19(14-4-6-16(23)7-5-14)29-30(22-28-27-13(3)31(21)22)10-15-8-17(24)9-26-20(15)25/h4-9H,10H2,1-3H3 DVRLGAKZPCPRHV-UHFFFAOYSA-N 527613 US11186588, Example 88 Nuclear factor NF-kappa-B p105 subunit Human 631 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527613 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527613&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717605 463791185 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114946 COc1ncc(F)cc1CN1N=C(c2c(C)c(C)sc2-n2c(C)nnc12)c1ccc(Cl)cc1 InChI=1S/C23H20ClFN6OS/c1-12-13(2)33-22-19(12)20(15-5-7-17(24)8-6-15)29-30(23-28-27-14(3)31(22)23)11-16-9-18(25)10-26-21(16)32-4/h5-10H,11H2,1-4H3 GEAHCVDIHAPFQN-UHFFFAOYSA-N 527614 US11186588, Example 89 Nuclear factor NF-kappa-B p105 subunit Human 556 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527614 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527614&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717639 463791186 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114947 Cc1nnc2N(Cc3cccnc3F)N=C(c3c(C)c(C)sc3-n12)c1ccccc1 InChI=1S/C22H19FN6S/c1-13-14(2)30-21-18(13)19(16-8-5-4-6-9-16)27-28(22-26-25-15(3)29(21)22)12-17-10-7-11-24-20(17)23/h4-11H,12H2,1-3H3 CXZHNBWPYRPFLO-UHFFFAOYSA-N 527615 Synthesis of::US11186588, Example 90 Nuclear factor NF-kappa-B p105 subunit Human 298 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527615 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527615&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 146478973 463791187 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114948 Cc1nnc2N(Cc3cccnc3)N=C(c3c(C)c(C)sc3-n12)c1ccc(N)cc1 InChI=1S/C22H21N7S/c1-13-14(2)30-21-19(13)20(17-6-8-18(23)9-7-17)27-28(12-16-5-4-10-24-11-16)22-26-25-15(3)29(21)22/h4-11H,12,23H2,1-3H3 DGWMDETUPIFFOQ-UHFFFAOYSA-N 527616 US11186588, Example 92 Nuclear factor NF-kappa-B p105 subunit Human 34.2 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527616 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527616&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717582 463791188 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114949 CC(=O)Nc1ccc(cc1)C1=NNc2nnc(C)n2-c2sc(C)c(C)c12 InChI=1S/C18H18N6OS/c1-9-10(2)26-17-15(9)16(21-23-18-22-20-11(3)24(17)18)13-5-7-14(8-6-13)19-12(4)25/h5-8H,1-4H3,(H,19,25)(H,22,23) FVEXCKFACOUYIH-UHFFFAOYSA-N 527617 N-(4-(2,3,9-trimethyl-6H-thieno[2,3-e][1,2,4]triazolo[3,4-c][1,2,4]triazepin-4-yl)phenyl)acetamide::US11186588, Example 94 Nuclear factor NF-kappa-B p105 subunit Human 96.0 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527617 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527617&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717526 463791189 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114950 COc1cncc(CNNC(=O)OC(C)(C)C)c1 InChI=1S/C12H19N3O3/c1-12(2,3)18-11(16)15-14-7-9-5-10(17-4)8-13-6-9/h5-6,8,14H,7H2,1-4H3,(H,15,16) QBUXRDGFSWQGGB-UHFFFAOYSA-N 527618 US11186588, Example 103::US11186588, Example 99 Nuclear factor NF-kappa-B p105 subunit Human 1644 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527618 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527618&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717484 463791190 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114951 COc1cncc(CNNC(=O)OC(C)(C)C)c1 InChI=1S/C12H19N3O3/c1-12(2,3)18-11(16)15-14-7-9-5-10(17-4)8-13-6-9/h5-6,8,14H,7H2,1-4H3,(H,15,16) QBUXRDGFSWQGGB-UHFFFAOYSA-N 527618 US11186588, Example 103::US11186588, Example 99 Nuclear factor NF-kappa-B p105 subunit Human 289 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527618 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527618&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717484 463791190 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114952 CC(=O)Nc1ccc(cc1)C(=O)c1c(C)c(C)sc1N=C=S InChI=1S/C16H14N2O2S2/c1-9-10(2)22-16(17-8-21)14(9)15(20)12-4-6-13(7-5-12)18-11(3)19/h4-7H,1-3H3,(H,18,19) AKBAALKMWMRPMD-UHFFFAOYSA-N 527620 US11186588, Example 104 Nuclear factor NF-kappa-B p105 subunit Human 3944 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527620 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527620&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717558 463791191 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114953 Cc1sc-2c(c1C)C(=NN(Cc1cccnc1)c1nnc(CO)n-21)c1ccc(N)cc1 InChI=1S/C22H21N7OS/c1-13-14(2)31-21-19(13)20(16-5-7-17(23)8-6-16)27-28(11-15-4-3-9-24-10-15)22-26-25-18(12-30)29(21)22/h3-10,30H,11-12,23H2,1-2H3 URSRIQJAHDPTJB-UHFFFAOYSA-N 527621 US11186588, Example 105 Nuclear factor NF-kappa-B p105 subunit Human 4833 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527621 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527621&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717510 463791192 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114954 Cc1nnc2N(Cc3cccnc3)N=C(c3c(C)c(CO)sc3-n12)c1ccc(N)cc1 InChI=1S/C22H21N7OS/c1-13-18(12-30)31-21-19(13)20(16-5-7-17(23)8-6-16)27-28(11-15-4-3-9-24-10-15)22-26-25-14(2)29(21)22/h3-10,30H,11-12,23H2,1-2H3 DZWZVZWWEIDUDW-UHFFFAOYSA-N 527622 US11186588, Example 106 Nuclear factor NF-kappa-B p105 subunit Human 1838 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527622 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527622&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717595 463791193 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114955 CC(=O)Nc1ccc(cc1)C(=O)c1c(CBr)c(C)sc1N1C(=O)c2ccccc2C1=O InChI=1S/C23H17BrN2O4S/c1-12-18(11-24)19(20(28)14-7-9-15(10-8-14)25-13(2)27)23(31-12)26-21(29)16-5-3-4-6-17(16)22(26)30/h3-10H,11H2,1-2H3,(H,25,27) AGNAYPVIOCMRPX-UHFFFAOYSA-N 527623 US11186588, Example 107 Nuclear factor NF-kappa-B p105 subunit Human 2317 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527623 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527623&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717643 463791194 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1114956 Cc1nnc2N(Cc3cccnc3)N=C(c3c(CCO)csc3-n12)c1ccc(N)cc1 InChI=1S/C22H21N7OS/c1-14-25-26-22-28(12-15-3-2-9-24-11-15)27-20(16-4-6-18(23)7-5-16)19-17(8-10-30)13-31-21(19)29(14)22/h2-7,9,11,13,30H,8,10,12,23H2,1H3 ARRSUTUZFMINFY-UHFFFAOYSA-N 527624 US11186588, Example 108 Nuclear factor NF-kappa-B p105 subunit Human 4020 US Patent 10.7270/Q21R6TQ4 aid1806139 US11186588 Aono, H; Seki, I; Imamura, M; Tanaka, T; Shirae, S; Kawashima, K; Yamazaki, Y; Yamamoto, M 11/30/2021 4/10/2022 AYUMI PHARMACEUTICAL CORPORATION http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=527624 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=527624&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 141717511 463791195 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 1NFI,1SVC,2O61 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0